Sara Hall
31 – 40 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
- Contribution to journal › Article
-
Mark
CSF biomarkers and clinical progression of Parkinson disease.
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
- Contribution to journal › Article
- 2014
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
(2014) In Journal of Alzheimer's Disease
- Contribution to journal › Article
- 2013
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
- Contribution to journal › Article
-
Mark
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment.
- Contribution to journal › Article
-
Mark
A beta 1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
- Contribution to journal › Article
- 2012
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- Contribution to journal › Article
